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Microwave Sterilization and Depyrogenation System
Lightweight and portable systems can be deployed to provide medical-grade water.
John H. Glenn Research Center, Cleveland, Ohio
A fully functional, microgravity-com-
patible microwave sterilization and depy-
rogenation system (MSDS) prototype
was developed that is capable of produc-
ing medical-grade water (MGW) without
expendable supplies, using NASA
potable water that currently is available
aboard the International Space Station
(ISS) and will be available for Lunar and
planetary missions in the future. The mi-
crowave-based, continuous MSDS effi-
ciently couples microwaves to a single-
phase, pressurized, flowing water stream
that is rapidly heated above 150 ºC.
Under these conditions, water is rapidly
sterilized. Endotoxins, significant bio-
logical toxins that originate from the
cell walls of gram-negative bacteria and
which represent another defining MGW
requirement, are also deactivated (i.e.,
depyrogenated) albeit more slowly, with
such deactivation representing a more
difficult challenge than sterilization.
Several innovations culminated in the
successful MSDS prototype design. The
most significant is the antenna-directed
microwave heating of a water stream
flowing through a microwave steriliza-
tion chamber (MSC). Novel antenna de-
signs were developed to increase mi-
crowave transmission efficiency. These
improvements resulted in greater than
95-percent absorption of incident mi-
crowaves. In addition, incorporation of
recuperative heat exchangers (RHxs) in
the design reduced the microwave
power required to heat a water stream
flowing at 15 mL/min to 170 ºC to only
50 W. Further improvements in energy
efficiency involved the employment of a
second antenna to redirect reflected mi-
crowaves back into the MSC, eliminating
the need for a water load and simplify-
ing MSDS design.
A quick connect (QC) is another in-
novation that can be sterilized and de-
pyrogenated at temperature, and then
cooled using a unique flow design, al-
lowing collection of MGW at atmos-
pheric pressure and 80 ºC. The final in-
novation was the use of in-line mixers
incorporated in the flow path to disrupt
laminar flow and increase contact time
at a given flow rate.
These technologies can be employed
in small-scale systems for efficient pro-
duction of MGW in the laboratory or in
a range of larger systems that meet vari-
ous industrial requirements. The mi-
crowave antennas can also be adapted to
selectively sterilize vulnerable connec-
tions to ultra-pure water production fa-
cilities or biologically vulnerable systems
where microorganisms may intrude. 
This work was done by James R. Akse,
Roger W. Dahl, and Richard R. Wheeler, Jr.,
of UMPQUA Research Co. for Glenn Re-
search Center. Further information is con-
tained in a TSP (see page 1).
Inquiries concerning rights for the commer-
cial use of this invention should be addressed
to NASA Glenn Research Center, Innovative
Partnerships Office, Attn: Steve Fedor, Mail
Stop 4–8, 21000 Brookpark Road, Cleve-
land, Ohio 44135. Refer to LEW-18455-1.
Bio-Medical
VESGEN is a newly automated, user-
interactive program that maps and
quantifies the effects of vascular thera-
peutics and regulators on microvascu-
lar form and function. VESGEN ana-
lyzes two-dimensional, black and white
vascular images by measuring impor-
tant vessel morphology parameters.
This software guides the user through
each required step of the analysis
process via a concise graphical user in-
terface (GUI). There are control op-
tions ranging from “one-click” analysis
given a primary output, to step-by-step
control over each image and algorithm
used in an analysis. An option is pro-
vided to select a vascular tissue type,
which determines the general collec-
tions of algorithms, intermediate im-
ages, and output images and measure-
ments that will be produced. The UI
automatically restructures itself to pro-
vide customized user controls for
studying the requested type of tissue.
Three major types of vascular tissues
can be analyzed: branching trees, net-
works, and tree-network composites.
Parameters measured include vessel
diameter, length, branchpoints, den-
sity, and fractal dimension. For tree
type vessels, those measurements, as
well as the number and tortuosity of
vessels, are reported as dependent
functions of vessel branching genera-
tion. VESGEN uses the fundamental
image-processing concepts of 8-neigh-
bor pixel connectivity, skeleton and
distance map to create typically 5 to 12
(or greater) generations of vascular
branching from a single parent vessel.
For network type vessels, measure-
ments of avascular regions are also
made. Measurements of tree-network
composites combine aspects of tree
and network analyses.
Primary applications of the VESGEN code
are 2D vascular images acquired as clinical
diagnostic images of the human retina and as
experimental studies of the effects of vascu-
lar regulators and therapeutics on vessel re-
modeling. Appli cations of VESGEN will be
extended to predictive modeling studies of
the response of human normal and patho-
logical microvasculature to vascular thera-
peutics and regulators and to 3D vascular
trees that are characteristic of organs such as
the lung and brain.
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